The discovery of recurrent ETS gene fusions in prostate cancer has improved our understanding of prostate carcinogenesis and suggests novel targets for therapy. Here, Clark and Cooper discuss the variety of ETS gene fusions and their role in prostate cancer development, and outline the prognostic and therapeutic implications of this knowledge.
- Jeremy P. Clark
- Colin S. Cooper
